Big Data Business Development Development Life Science 
pharmaphorum
FEBRUARY 1, 2022
David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. His research focuses on the development of big data machine learning for tracking the health of complex systems. Mark holds a PhD in biomedicine, and an MSc in biostatistics.
pharmaphorum
FEBRUARY 11, 2022
Instead, Komodo’s software is the gateway to the Map’s data. One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. The business of data. Our software is deployed across two dimensions. About the author.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 30, 2022
The company developed the first FDA-authorised at-home VR pain treatment, RelieVRx, indicated as an adjunctive treatment for chronic lower back pain. He oversees operations, including business development, sales and marketing, and people. Distinct offerings. AppliedVR creates VR-based treatments aimed at relieving chronic pain.
Drug Discovery World
SEPTEMBER 6, 2022
DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year. . For cell and gene therapies, Covid-19 was a “double-edged sword”, according to Kristin Thompson, Chief Business Officer at eureKARE.
XTalks
AUGUST 2, 2023
is a global pharmaceutical company, working across both developed and emerging markets. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. Pfizer Inc.
Expert insights. Personalized for you.
100 
Let's personalize your content